Oral Steroids

Methyldrostanolone (Superdrol) 10 mg Astera Labs

Astera Labs

55,00

In Stock (100 available)

Methyldrostanolone (Superdrol) 10 mg Astera Labs (10 mg) — Drostanolone is the quintessential pre-contest compound — a DHT-derived injectable that produces a granite-hard, deeply striated…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost
Categories: ,

Description

Drostanolone (Masteron), Astera Labs, 10 mg. DHT-class anti-estrogenic anabolic with minimal side-effect burden relative to its visual impact. Low-bodyfat cutting staple; Propionate for EOD schedules, Enanthate for 2×-weekly flexibility.

Key Benefits

  • Superdrol — one of the most potent oral anabolics ever commercialised
  • Rapid strength and lean mass in 2–4 weeks
  • Does not aromatise — zero water, zero bloat
  • Extreme hepatotoxicity — short cycles mandatory
  • Not for beginners, not for back-to-back runs
  • Each unit dosed at 10 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 10–30 mg/day for 2–4 weeks. Most users see full effect at 10–20 mg. Above 30 mg/day liver enzymes spike severely. Cycles over 4 weeks are inadvisable.

How It Works

17α-methyl 2α,17β-dimethyl DHT-derivative. Potent AR agonist with zero aromatisation and zero progestagenic activity — pure lean-mass accrual. Extreme strength gains in first week. Lipid-profile devastation within 2 weeks.

Pharmacokinetics

Plasma half-life approximately 8 hours. Split daily dose 2–3×. Among the MOST hepatotoxic orals in commercial use. ALT/AST at week 2 and week 4 non-negotiable. Aggressive liver support (TUDCA 500 mg/day + NAC 1200 mg/day) from day 1.

Cycle & Stacking Guide

Short mass-cycle kickstart: 10–20 mg/day weeks 1–3 or 1–4 alongside a testosterone base (test E 500 mg/week). Drop superdrol at week 4, continue the injectable. Full liver panel before, during (week 2), and 4 weeks post-cycle.

Manufacturer Notes

Astera Labs produces a broad catalogue from research peptides to AAS oils. Lyophilised peptide vials ship with stability documentation.

Storage & Handling

Store upright at 15–25 °C in the original box, protected from light and moisture. Oil-based injectables are shelf-stable for the duration printed on the vial when kept at controlled room temperature. Do not refrigerate — cold thickens the carrier oil and makes drawing/injecting harder. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Methyldrostanolone (Superdrol) 10 mg Astera Labs”

Your email address will not be published. Required fields are marked *

Methyldrostanolone

Physical & Chemical Properties for Research Purposes
Chemical structure of Methyldrostanolone (C21H34O2) for laboratory analysis
2D structural representation · PubChem CID 169011 ↗
Chemical Identity
# CAS Registry Number 3381-88-2
Σ IUPAC Name (2R,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2,10,13,17-tetramethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one
F Molecular Formula C21H34O2
M Molecular Weight 318.49 g/mol
SMILES C[C@]1(O)CC[C@@H]2[C@H]3CC[C@@H]4CC(=O)[C@@H](C)C[C@]4(C)[C@@H]3CC[C@@]12C
InChIKey ABCYRJJFUXJLBF-UHFFFAOYSA-N
Melting Point 223-225 °C
Solubility Practically insoluble in water; soluble in ethanol, chloroform
Biological Half-life 8-12 hours (oral)
PubChem CID 169011 ↗
Pharmacological Profile
Anabolic Rating 400
Androgenic Rating 20
Aromatization None
Hepatotoxicity High
Detection Time 6-8 weeks
Known trade names: Superdrol, Methasterone, M-Drol

Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.